Adaptive Biotechnologies Quarterly Balance Sheet
NASDAQ: ADPTHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Adaptive Biotechnologies financial position
As of Jun 30, 2026, Adaptive Biotechnologies reported total assets of $640.7 million, up 29.0% from a year earlier against total liabilities of $490.0 million. Shareholders' equity stood at $142.9 million, or 22.3% of assets. The company held $169.9 million in cash and equivalents against $0 of debt, a net cash position of $169.9 million.
The current ratio (current assets divided by current liabilities) was 4.79, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.00.
Summary generated from market data by MetaCap's automated system. Methodology
Adaptive Biotechnologies balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 169.87M | 77.58M | 70.50M | 55.03M | 43.16M | 50.65M | 47.92M | 38.08M | 59.82M | 71.23M | 65.06M | 88.71M |
| Short-Term Investments | 174.38M | 140.75M | 156.49M | 157.74M | 154.71M | 142.78M | 174.37M | 205.25M | 232.06M | 237.64M | 281.34M | 282.42M |
| Receivables | 49.51M | 48.31M | 50.37M | 44.82M | 44.28M | 43.58M | 41.73M | 40.81M | 35.61M | 42.02M | 37.97M | 31.21M |
| Inventory | 10.50M | 11.21M | 9.82M | 9.93M | 8.40M | 8.68M | 8.44M | 11.96M | 13.21M | 13.29M | 14.45M | 19.49M |
| Total Current Assets | 420.56M | 291.81M | 300.19M | 281.44M | 261.86M | 256.49M | 283.75M | 308.35M | 351.55M | 374.03M | 410.19M | 435.24M |
| Property, Plant & Equipment | 29.45M | 30.77M | 34.11M | 37.50M | 41.05M | 44.43M | 48.62M | 51.31M | 55.42M | 65.26M | 68.23M | 76.75M |
| Goodwill | 118.97M | 118.97M | 118.97M | 118.97M | 118.97M | 118.97M | 118.97M | 118.97M | 118.97M | 118.97M | 118.97M | 118.97M |
| Intangible Assets | 884.00K | 1.31M | 1.73M | 2.15M | 2.58M | 3.01M | 3.42M | 3.85M | 4.28M | 4.71M | 5.13M | 5.56M |
| Long-Term Investments | 27.48M | 18.89M | 13.23M | 4.04M | 24.10M | 39.35M | 33.66M | 23.87M | — | — | — | — |
| Total Assets | 640.68M | 505.94M | 512.74M | 490.61M | 496.64M | 510.85M | 539.38M | 558.51M | 584.87M | 620.32M | 661.13M | 717.68M |
| Accounts Payable | 5.24M | 9.62M | 6.47M | 10.27M | 6.91M | 6.36M | 7.26M | 7.35M | 9.87M | 12.17M | 7.72M | 4.48M |
| Short-Term Debt | 0 | 5.80M | 4.64M | 2.43M | 3.07M | 2.01M | 865.00K | — | — | — | — | 3.19M |
| Total Current Liabilities | 87.71M | 87.01M | 89.92M | 83.36M | 92.14M | 87.81M | 98.05M | 87.63M | 88.13M | 82.95M | 88.02M | 93.30M |
| Long-Term Debt | 0 | 124.75M | 126.57M | 129.41M | 130.50M | 131.55M | 132.41M | 132.70M | 132.08M | 131.54M | 130.66M | 126.73M |
| Total Liabilities | 490.02M | 281.70M | 287.74M | 286.36M | 317.10M | 320.63M | 336.89M | 334.93M | 343.44M | 345.56M | 352.86M | 356.05M |
| Shareholders' Equity | 142.91M | 216.34M | 218.79M | 204.44M | 179.72M | 190.42M | 202.71M | 223.77M | 241.60M | 274.91M | 308.40M | 361.73M |
| Retained Earnings | -1.42B | -1.38B | -1.36B | -1.35B | -1.36B | -1.33B | -1.30B | -1.27B | -1.24B | -1.19B | -1.14B | -1.07B |
| Total Debt | 0 | 130.55M | 131.21M | 131.84M | 133.56M | 133.56M | 133.28M | 132.70M | 132.08M | 131.54M | 130.66M | 129.92M |
| Net Cash (Debt) | 344.25M | 87.78M | 95.77M | 80.93M | 64.31M | 59.86M | 89.02M | 110.63M | 159.80M | 177.33M | 215.74M | 241.21M |
| Shares Outstanding | 159.06M | 159.70M | 153.78M | 152.58M | 152.23M | 151.92M | 147.77M | 147.56M | 147.46M | 147.37M | 145.08M | 144.77M |
This table shows 12 quarterly periods of Adaptive Biotechnologies's balance sheet, from Q2 2026 back to Q3 2023, across 20 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow ADPT's reporting calendar. What is a balance sheet?